Toxicological assessment of leachates and leached substances from degraded plastic species using in-vitro bioassays

2021 ◽  
Vol 350 ◽  
pp. S202
Author(s):  
H. Pannekens ◽  
W. Newe ◽  
S. Wegener ◽  
G. Schertzinger ◽  
E. Dopp
2021 ◽  
pp. 096032712110227
Author(s):  
S Kara-Ertekin ◽  
S Yazar ◽  
M Erkan

Pyrethroid pesticides are frequently used for household insect control of insects and in agriculture and livestock. Flumethrin is a pyrethroid that is used against ectoparasites in many animals. The goal of this study was to evaluate the cytotoxic, apoptotic, genotoxic, and estrogenic effects of flumethrin on the mammalian breast cancer cell line (MCF-7). Compared with control groups, a dose-dependent decrease was observed in cell viability at concentrations of 100 µM and higher. The cytotoxic and apoptotic effects detected by LDH assay and AO/EtBr staining increased significantly at a concentration of 1000 µM. The expression of BCL2, which is an anti-apoptotic gene, significantly decreased, whereas BAX, TP53, and P21 expression significantly increased. The results of a comet assay indicated that flumethrin significantly changed tail length, tail % DNA, tail moment, and Olive tail moment in concentrations above 1 and 10 µM. In addition, a 0.1 µM concentration of flumethrin affected ERα receptor mediated cell proliferation and increased transcription of estrogen-responsive pS2 (TFF1) and progesterone receptor (PGR) genes. As a result, flumethrin-induced apoptosis and cytotoxicity at a high concentration, while induced genotoxicity even at lower concentrations. Flumethrin is an endocrine disrupting insecticide with estrogenic effects at very low concentrations.


2021 ◽  
Author(s):  
Rachel A. Lund ◽  
Elliot R. Cooper ◽  
Hui Wang ◽  
Zoe Ashley ◽  
Adam T. Cawley ◽  
...  

2007 ◽  
Vol 33 (7) ◽  
pp. 859-866 ◽  
Author(s):  
M. Škarek ◽  
J. Janošek ◽  
P. Čupr ◽  
J. Kohoutek ◽  
A. Novotná-Rychetská ◽  
...  

2013 ◽  
Vol 32 (5) ◽  
pp. 385-394 ◽  
Author(s):  
Antoinette Y. Odendaal ◽  
Narendra S. Deshmukh ◽  
Tennille K. Marx ◽  
Alexander G. Schauss ◽  
John R. Endres ◽  
...  

This toxicological assessment evaluated the safety of a hydroethanolic extract prepared from Caralluma fimbriata (CFE), a dietary supplement marketed worldwide as an appetite suppressant. Studies included 2 in vitro genotoxicity assays, a repeated dose oral toxicity study, and a developmental study in rats. No evidence of in vitro mutagenicity or clastogenicity surfaced in the in vitro studies at concentrations up to 5000 μg of extract/plate (Ames test) or 5000 μg of extract/mL (chromosomal aberration test). No deaths or treatment-related toxicity were seen in the 6-month chronic oral toxicity study in Sprague-Dawley rats conducted at 3 doses (100, 300, and 1000 mg/kg body weight (bw)/d). The no observed effect level for CFE in this study was considered to be 1000 mg/kg bw/d. A prenatal developmental toxicity study conducted at 3 doses (250, 500, and 1000 mg/kg bw/d) in female Sprague-Dawley rats resulted in no treatment-related external, visceral, or skeletal fetal abnormalities, and no treatment-related maternal or pregnancy alterations were seen at and up to the maximum dose tested. CFE was not associated with any toxicity or adverse events.


2015 ◽  
Vol 15 (4) ◽  
pp. 1412-1421 ◽  
Author(s):  
Pei-Hsin Chou ◽  
Chen-Hua Lee ◽  
Fung-Chi Ko ◽  
You-Ji Lin ◽  
Masanobu Kawanishi ◽  
...  

2017 ◽  
Vol 22 (8) ◽  
pp. 1187-1200 ◽  
Author(s):  
Gerhard Prinsloo ◽  
Georgia Papadi ◽  
Mebrahtom G. Hiben ◽  
Laura de Haan ◽  
Jochem Louisse ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document